Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


GIMV sells its stake in Hypnion


Following the earlier release of 5 March 2007, GIMV announces that it has sold its stake in drug discovery and development company Hypnion (www.hypnion.com) to Eli Lilly & Company (www.lilly.com). Hypnion is a privately owned neuroscience drug discovery and development company that is focused on sleep disorders. Last January, Hypnion announced that its compound HY10275 met the primary and secondary endpoints in the company’s initial phase II clinical trials.

Eli Lilly acquired Hypnion for a total amount of USD 315 million. GIMV was a minority shareholder of Hypnion since 2000, took part in both the Series-A and Series-B financing rounds, and now sells its stake in Hypnion together with all other shareholders to Eli Lilly & Company.

The sale has a positive impact of EUR 12.4 million (EUR 0.53 per share) on GIMV’s last published equity value at 31 December 2006.

Since its incorporation in 1980 GIMV has grown into Belgium's most important venture capital provider and companybuilder. GIMV has now become a major European and international market player. Both in Belgium and abroad, GIMV invests in information and communication technology, life sciences as well as in growth financing and management buyouts (MBOs) of companies in more traditional sectors. GIMV currently manages around EUR 1.5 billion of assets (including third party funds). GIMV has been listed on Euronext Brussels since 1997.
For more information on GIMV, please go to www.gimv.com.


Publisher Contact Information:

GIMV N.V.
+32 3 290 22 18
frankdl@gimv.be

Company profile of GIMV N.V.
Past press releases of GIMV N.V. .

Data


26,673
Tech investments
From our Online Data Service
17,217
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Nov 25€24.0MInternet commerce
Feb 14€19.0MBiopharmaceuticals
Feb 14N/AInternet services
Feb 14€4.6MBusiness applications
Feb 13€13.0MBiopharmaceuticals
Feb 13€25.0MMedical devices
Feb 13€15.0MBusiness applications

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Jan 29
Yumpingo
yumpingo raises $10m to transform guest experiences in restaurants

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.